Isofol (Sweden)

Recent papers from Isofol (Sweden)

1. Abstract CT218: Phase 1b/2 study of arfolitixorin in combination with 5-fluorouracil (5FU), oxaliplatin, and bevacizumab as first-line therapy for metastatic colorectal cancer (mCRC)Cancer Research · 2026
2. Phase 1b/2 study of arfolitixorin in combination with 5-fluorouracil (5FU), oxaliplatin, and bevacizumab as first-line therapy for metastatic colorectal cancer (mCRC).Journal of Clinical Oncology · 2026
3. "S med en liten fjång nertill"Nordic Journal of Socio-Onomastics · 2025
4. Folate‐Associated Gene Expression in Primary Tumors Is Associated With Tumor Response and Progression‐Free Survival of Patients With Metastatic Colorectal Cancer Undergoing 5‐ FU /Leucovorin‐Based Combination ChemotherapyCancer Medicine · 2025
5. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT TrialCancer Research Communications · 2023
6. A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancerESMO Open · 2022
7. Characterization of Complex Optical Modulation Formats at 100 Gb/s and Beyond by Coherent Optical SamplingJournal of Lightwave Technology · 2012
8. Performance Comparison of Differential 8-Ary Modulation Formats in High-Speed Optical Transmission SystemsJournal of Lightwave Technology · 2011